Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-Mcs-012	DOPG:Chol:PEG2000:NBD-lipid (65:29:5:1 molar ratio)	The specified lipid formulation (DOPG:Chol:PEG2000:NBD-lipid in 65:29:5:1 molar ratio) is designed to combine stability, stealth characteristics, and functionality for applications in drug delivery, vaccine formulation, and biological imaging.	price>
R-Mcs-013	DOPG:DOPC:Chol:PEG2000:NBD-lipid	The specified lipid formulation (DOPG:DOPC:Chol:PEG2000:NBD-lipid) provides a versatile platform for drug delivery, vaccine development, and biophysical studies. The combination of anionic and neutral lipids, alongside cholesterol and PEG, enhances the stability, circulation time, and functionality of the liposomes, making them suitable for various applications in biomedicine.	price>
R-Mcs-014	DOPG:Chol:PEG2000:Rhod-lipid (65:29:5:1 molar ratio)	The lipid formulation of DOPG:Chol:PEG2000:Rhod-lipid in a 65:29:5:1 molar ratio provides a versatile tool for various biomedical applications, including drug delivery, vaccine development, and bioimaging. The balance of anionic and sterically stabilized components aids in optimizing interaction with biological systems while allowing for effective tracking and visualization of the behavior of system.	price>
R-Mcs-015	DOPG:DOPC:Chol:PEG2000:Rhod-lipid	The formulation of DOPG:DOPC:Chol:PEG2000:Rhod-lipid offers a versatile platform for various biomedical applications, particularly in drug delivery and bioimaging. The careful choice of lipid components allows for fine-tuning of the physical and chemical properties of the liposomes, enabling optimized interactions with biological systems while providing a method for tracking their behavior in real-time.	price>
R-Mcs-020	PS:Chol:PEG2000:NBD-lipid (65:29:5:1 molar ratio)	The PS:Chol:PEG2000:NBD-lipid (65:29:5:1) formulation is optimized for effective drug delivery systems with enhanced cellular targeting, stability, and the capability for in vivo imaging. The careful balance of components allows for both therapeutic delivery and excellent tracking capabilities in preclinical and clinical research settings.	price>
R-Mcs-021	PS:PC:Chol:PEG2000:NBD-lipid	The PS:PC:Chol:PEG2000:NBD-lipid/L-alpha-phosphatidylserine:L-alpha-phosphatidylcholine:Cholesterol:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt):1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) formulation is versatile and can be tailored for applications in drug delivery, cellular targeting, and imaging. Such a system capitalizes on the benefits of each component, leading to enhanced therapeutic efficacy and improved diagnostic capabilities. The formulation process, combined with appropriate characterization techniques, will allow you to optimize liposome properties for specific application requirements.	price>
R-Mcs-022	PS:Chol:PEG2000:Rhod-lipid (65:29:5:1 molar ratio)	The PS:Chol:PEG2000:Rhod-lipid/L-alpha-phosphatidylserine:Cholesterol:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt):1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE) formulation at a 65:29:5:1 molar ratio represents a well-balanced system for various biomedical applications centered around drug delivery and imaging. The formulation harnesses the unique properties of each component to enhance efficacy and tracking capabilities. By optimizing the preparation process and conducting thorough characterization, this formulation can be effectively utilized for targeted therapies and research applications.	price>
R-Mcs-023	PS:PC:Chol:PEG2000:Rhod-lipid	The PS:PC:Chol:PEG2000:Rhod-lipid/L-alpha-phosphatidylserine:L-alpha-phosphatidylcholine:Cholesterol:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt):1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE) formulation can be an advanced lipid system useful for a variety of biomedical applications. The unique properties brought by each component synergistically enhance the formulation’s functionality, making it suitable for drug delivery, imaging, and vaccine development. Fine-tuning the composition can further optimize performance based on specific research or therapeutic objectives.	price>
R-Mcs-024	DOTAP:Chol:PEG2000:NBD-lipid (65:29:5:1 molar ratio)	The DOTAP:Chol:PEG2000:NBD-lipid/1,2-dioleoyl-3-trimethylammonium-propane (chloride salt):Cholesterol:1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (ammonium salt):1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) formulation at a 65:29:5:1 molar ratio provides a complex system optimized for gene delivery, cellular imaging, and possibly vaccine applications. Each component plays a crucial role in enhancing the formulation performance, stability, and ability to interact with biological systems.	price>
R-Mcs-025	DOTAP:DOPC:Chol:PEG2000:NBD-lipid	The DOTAP:DOPC:Chol:PEG2000:NBD-lipid/1,2-dioleoyl-3-trimethylammonium-propane (chloride salt):1,2-dioleoyl-sn-glycero-3-phosphocholine:Cholesterol:1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt):1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) formulation is a versatile and effective system for applications in gene delivery, drug delivery, and imaging.	price>

...